series-c-plus
Stage
1
Investors
About
Orgenesis develops platforms, services and manufacturing solutions for cell and gene therapies, enabling decentralized near‑patient production, quality control and clinical support to biopharma partners and healthcare providers.
Explore Orgenesis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.